拱东医疗实控人方及总经理终止减持 已套现5170万元

Core Viewpoint - Gongdong Medical (605369.SH) announced the early termination of the share reduction plan by major shareholders and the results of the share reduction [1] Group 1: Share Reduction Details - The company disclosed that Taizhou Jincheng Investment Management Partnership (Limited Partnership) planned to reduce its holdings by up to 1,575,784 shares, representing 1% of the total share capital [1] - The company's general manager, Zhong Weifeng, intended to reduce his holdings by up to 302,158 shares, accounting for 0.19% of the total share capital [1] - As of May 30, 2025, Jincheng Investment had reduced its holdings by 1,575,708 shares, while Zhong Weifeng had reduced 294,936 shares [1] Group 2: Financial Impact of Share Reduction - Zhong Weifeng's share reduction occurred between March 13, 2025, and May 30, 2025, with a total amount of 8,526,906.60 yuan at a price range of 28.08 to 30.98 yuan per share [2] - Jincheng Investment reduced its holdings from March 11, 2025, to May 30, 2025, totaling 43,171,696.32 yuan at a price range of 23.64 to 30.53 yuan per share [2] - The combined total amount from both parties' share reductions was 51,698,602.92 yuan [2] Group 3: Shareholding Structure - Prior to the reductions, Zhong Weifeng held 1,208,634 shares (0.77% of total share capital), while Jincheng Investment held 11,760,000 shares (7.46% of total share capital) [2] - After the reductions, Zhong Weifeng's holdings decreased to 913,698 shares (0.58%), and Jincheng Investment's holdings decreased to 10,184,292 shares (6.46%) [2] - The major shareholders, including Shi Huiyong and Shi Yibei, collectively held 102,688,600 shares, representing 65.17% of the total share capital [2][3]